Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

AGA clinical practice update: Pancreatic cancer screening

Key clinical point: Patients with high pancreatic cancer risk should be considered for screening.

Major finding: Two first-degree relatives with pancreatic cancer confers an 8%-12% lifetime risk.

Study details: Expert review commissioned by the American Gastroenterological Association Institute Clinical Practice Updates Committee.

Disclosures: Harry R. Aslanian, MD, AGAF, and coauthors did not provide any disclosures.

Source: Aslanian HR et al. Gastroenterology. 2020. doi: 10.1053/j.gastro.2020.03.088.

Citation:

Aslanian HR et al. Gastroenterology. 2020. doi: 10.1053/j.gastro.2020.03.088.